Lithium Controlled-Release and Extended-Release Tablets and Ustekinumab Subcutaneous Injection
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Ustekinumab Subcutaneous Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Ustell
- Lithium Controlled-Release and Extended-Release Tablets-UTA
- Lithium Controlled-Release and Extended-Release Tablets-UTA Capsules
- Lithium Controlled-Release and Extended-Release Tablets-UTAC tablets
- Lithium Controlled-Release and Extended-Release Tablets-UTI Relief
- Lithium Controlled-Release and Extended-Release Tablets-Utibron Neohaler
- Ustekinumab Subcutaneous Injection-Lithium ER
- Ustekinumab Subcutaneous Injection-Lithium Oral Solution
- Ustekinumab Subcutaneous Injection-Lithium Salts
- Ustekinumab Subcutaneous Injection-Lithium Syrup and Oral Solution
- Ustekinumab Subcutaneous Injection-Lithobid
- Ustekinumab Subcutaneous Injection-Lithostat